» Articles » PMID: 34843662

Prevention of SARS-CoV-2 Transmission During a Large, Live, Indoor Gathering (SPRING): a Non-inferiority, Randomised, Controlled Trial

Abstract

Background: Mass indoor gatherings were banned in early 2020 to prevent the spread of SARS-CoV-2. We aimed to assess, under controlled conditions, whether infection rates among attendees at a large, indoor gathering event would be similar to those in non-attendees, given implementation of a comprehensive prevention strategy including antigen-screening within 3 days, medical mask wearing, and optimised ventilation.

Methods: The non-inferiority, prospective, open-label, randomised, controlled SPRING trial was done on attendees at a live indoor concert held in the Accor Arena on May 29, 2021 in Paris, France. Participants, aged 18-45 years, recruited via a dedicated website, had no comorbidities, COVID-19 symptoms, or recent case contact, and had had a negative rapid antigen diagnostic test within 3 days before the concert. Participants were randomly allocated in a 2:1 ratio to the experimental group (attendees) or to the control group (non-attendees). The allocation sequence was computer-generated by means of permuted blocks of sizes three, six, or nine, with no stratification. The primary outcome measure was the number of patients who were SARS-CoV-2-positive by RT-PCR test on self-collected saliva 7 days post-gathering in the per-protocol population (non-inferiority margin <0·35%). This trial is registered with ClinicalTrials.gov, NCT04872075.

Findings: Between May 11 and 25, 2021, 18 845 individuals registered on the dedicated website, and 10 953 were randomly selected for a pre-enrolment on-site visit. Among 6968 who kept the appointment and were screened, 6678 participants were randomly assigned (4451 were assigned to be attendees and 2227 to be non-attendees; median age 28 years; 59% women); 88% (3917) of attendees and 87% (1947) of non-attendees complied with follow-up requirements. The day 7 RT-PCR was positive for eight of the 3917 attendees (observed incidence, 0·20%; 95% CI 0·09-0·40) and three of the 1947 non-attendees (0·15%; 0·03-0·45; absolute difference, 95% CI -0·26% to 0·28%), findings that met the non-inferiority criterion for the primary endpoint.

Interpretation: Participation in a large, indoor, live gathering without physical distancing was not associated with increased SARS-CoV-2-transmission risk, provided a comprehensive preventive intervention was implemented.

Funding: French Ministry of Health.

Translation: For the French translation of the abstract see Supplementary Materials section.

Citing Articles

Comparing strategies for the mitigation of SARS-CoV-2 airborne infection risk in tiered auditorium venues.

Geisler S, Lausch K, Hehnen F, Schulz I, Kertzscher U, Kriegel M Commun Eng. 2024; 3(1):161.

PMID: 39521872 PMC: 11550442. DOI: 10.1038/s44172-024-00297-y.


Wind velocity and dispersion/advection-diffusion of artificial droplets and droplet nuclei in a domed all-weather multi-purpose stadium.

Shinohara N, Kurihara N, Naito W, Iwai A, Yasutaka T, Morioka T Sci Rep. 2024; 14(1):26601.

PMID: 39496673 PMC: 11535064. DOI: 10.1038/s41598-024-76806-y.


Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020-2022.

Galmiche S, Charmet T, Rakover A, Cheny O, Omar F, David C BMC Public Health. 2024; 24(1):2411.

PMID: 39232732 PMC: 11376041. DOI: 10.1186/s12889-024-19651-y.


Impact of the 2022 African Cup of Nations mass-gathering event on the COVID-19 epidemic in Garoua, Cameroon.

Berland J, Njifon H, Westeel E, Moumbeket H, Komurian-Pradel F, Ilouga P J Public Health (Oxf). 2024; 46(3):351-356.

PMID: 38762221 PMC: 11358624. DOI: 10.1093/pubmed/fdae072.


A self-controlled case series study to measure the risk of SARS-CoV-2 infection associated with attendance at sporting and cultural events: the UK Events Research Programme events.

Douglas I, Peh J, Mansfield K, Trelfa A, Fowler T, Boulter M BMC Med. 2024; 22(1):100.

PMID: 38448944 PMC: 10918946. DOI: 10.1186/s12916-024-03276-4.


References
1.
Stange M, Mari A, Roloff T, Seth-Smith H, Schweitzer M, Brunner M . SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event. PLoS Pathog. 2021; 17(3):e1009374. PMC: 8011817. DOI: 10.1371/journal.ppat.1009374. View

2.
Che Mat N, Edinur H, Azhar Abdul Razab M, Safuan S . A single mass gathering resulted in massive transmission of COVID-19 infections in Malaysia with further international spread. J Travel Med. 2020; 27(3). PMC: 7188142. DOI: 10.1093/jtm/taaa059. View

3.
Elachola H, Ebrahim S, Gozzer E . COVID-19: Facemask use prevalence in international airports in Asia, Europe and the Americas, March 2020. Travel Med Infect Dis. 2020; 35:101637. PMC: 7118530. DOI: 10.1016/j.tmaid.2020.101637. View

4.
Edwards D, Ausiello D, Salzman J, Devlin T, Langer R, Beddingfield B . Exhaled aerosol increases with COVID-19 infection, age, and obesity. Proc Natl Acad Sci U S A. 2021; 118(8). PMC: 7923364. DOI: 10.1073/pnas.2021830118. View

5.
Gerbaud L, Guiguet-Auclair C, Breysse F, Odoul J, Ouchchane L, Peterschmitt J . Hospital and Population-Based Evidence for COVID-19 Early Circulation in the East of France. Int J Environ Res Public Health. 2020; 17(19). PMC: 7579479. DOI: 10.3390/ijerph17197175. View